How Aspen is convincing the sceptics
Aspen is winning over the doubters after slashing debt and clinching the J&J deal. But it needs to build on its promises
09 September 2021 - 05:00
The term "Big Pharma" carries plenty of derogatory connotations. And even consumers who don’t subscribe to conspiracies involving vaccines and microchips love to hate drug companies.
But last Thursday was a chance for Aspen Pharmacare’s founder, Stephen Saad, to reflect on the progress his company has made in recent months...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.